Synaptic Polarity Depends on Phosphatidylinositol Signaling Regulated by myo-Inositol Monophosphatase in Caenorhabditis elegans

被引:17
|
作者
Kimata, Tsubasa
Tanizawa, Yoshinori
Can, Yoko
Ikeda, Shingo
Kuhara, Atsushi
Mori, Ikue [1 ,2 ]
机构
[1] Nagoya Univ, Dept Mol Biol, Mol Neurobiol Lab, Div Biol Sci,Grad Sch Sci, Nagoya, Aichi 4648602, Japan
[2] CREST, Tokyo 1020075, Japan
基金
日本学术振兴会; 日本科学技术振兴机构;
关键词
LITHIUM-TREATED RATS; C-ELEGANS; BIPOLAR DISORDER; NERVOUS-SYSTEM; UNIFYING HYPOTHESIS; INOSITOL DEPLETION; NEURONAL POLARITY; CANDIDATE GENE; KNOCKOUT MICE; BRAIN;
D O I
10.1534/genetics.111.137844
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Although neurons are highly polarized, how neuronal polarity is generated remains poorly understood. An evolutionarily conserved inositol-producing enzyme myo-inositol monophosphatase ( IMPase) is essential for polarized localization of synaptic molecules in Caenorhabditis elegans and can be inhibited by lithium, a drug for bipolar disorder. The synaptic defect of IMPase mutants causes defects in sensory behaviors including thermotaxis. Here we show that the abnormalities of IMPase mutants can be suppressed by mutations in two enzymes, phospholipase C beta or synaptojanin, which presumably reduce the level of membrane phosphatidylinositol 4,5-bisphosphate (PIP2). We also found that mutations in phospholipase C beta conferred resistance to lithium treatment. Our results suggest that reduction of PIP2 on plasma membrane is a major cause of abnormal synaptic polarity in IMPase mutants and provide the first in vivo evidence that lithium impairs neuronal PIP2 synthesis through inhibition of IMPase. We propose that the PIP2 signaling regulated by IMPase plays a novel and fundamental role in the synaptic polarity.
引用
收藏
页码:509 / U343
页数:21
相关论文
共 50 条
  • [1] Screening for inhibitors of human brain myo-inositol monophosphatase
    Ganzhorn, AJ
    Brunati, C
    Kugel, C
    Islam, K
    Galvan, M
    Chanal, MC
    Stefanelli, S
    Sponga, F
    Andreini, P
    Wolf, E
    Piriou, F
    Dulery, B
    Verne, J
    Lamard, M
    Wagner, J
    Danzin, C
    NEW FRONTIERS IN SCREENING FOR MICROBIAL BIOCATALYSTS, 1998, 53 : 103 - 109
  • [2] Inhibition of myo-inositol monophosphatase isoforms by aromatic phosphonates
    Ganzhorn, AJ
    Hoflack, J
    Pelton, PD
    Strasser, F
    Chanal, MC
    Piettre, SR
    BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (10) : 1865 - 1874
  • [3] Stereochemistry at phosphorus of the reaction catalyzed by myo-inositol monophosphatase
    Fauroux, CMJ
    Lee, M
    Cullis, PM
    Douglas, KT
    Gore, MG
    Freeman, S
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (06) : 1363 - 1373
  • [4] Phosphonocarboxylates and dicarboxylates as inhibitors of myo-inositol monophosphatase.
    Gaitonde, DY
    Gupta, A
    Lin, F
    Seybert, DW
    Harrold, MW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 159 - MEDI
  • [5] Biochemical and biological characterization of myo-inositol monophosphatase in Arabidopsis
    Donahue, Janet L.
    Torabinejad, Javad
    Gunesekera, Bhadra
    Gillaspy, Glenda
    FASEB JOURNAL, 2007, 21 (05): : A256 - A256
  • [6] Synthesis of arylalkylmonofluorophosphonates as myo-inositol monophosphatase ligands.
    Schmitt, L
    Cavusoglu, N
    Spiess, B
    Schlewer, G
    TETRAHEDRON LETTERS, 1998, 39 (23) : 4009 - 4012
  • [7] Alteration of myo-inositol monophosphatase in Alzheimer's disease brains
    Shimohama, S
    Tanino, H
    Sumida, Y
    Tsuda, J
    Fujimoto, S
    NEUROSCIENCE LETTERS, 1998, 245 (03) : 159 - 162
  • [9] Spectroscopic studies of myo-inositol monophosphatase with a novel fluorescent substrate
    Pineda, T
    Thorne, MJ
    Gore, MG
    Churchich, JE
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1996, 1292 (02): : 259 - 264
  • [10] myo-Inositol Monophosphatase: A Challenging Target for Mood Stabilising Drugs
    Miller, D. J.
    Allemann, R. K.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (02) : 107 - 113